Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Ralph Zahar

Showing results (31-40 of 190) with videos related to

Pageof 19
Sort By:
BMC Infectious Diseases|April 27, 2013
Limits of patient isolation measures to control extended-spectrum beta-lactamase-producing Enterobacteriaceae: model-based analysis of clinical data in a pediatric wardMatthieu Domenech de Cellès, Jean-Ralph Zahar, Véronique Abadie, et al.
Critical Care (London, England)|June 29, 2017
Treatment of severe hospital-acquired and ventilator-associated pneumonia: a systematic review of inclusion and judgment criteria used in randomized controlled trialsEmmanuel Weiss, Wafa Essaied, Christophe Adrie, et al.
Diagnostic Microbiology and Infectious Disease|December 23, 2019
Impact of freeze/thaw cycles and single freezing at -80 °C on the viability of aerobic bacteria from rectal swabs performed with the ESwab<sup>TM</sup> systemRindala Saliba, Jean Ralph Zahar, Fatma El Allaoui, et al.
Annals of Intensive Care|November 12, 2017
Piperacillin-tazobactam as alternative to carbapenems for ICU patientsBenoit Pilmis, Vincent Jullien, Alexis Tabah, et al.
Expert Opinion on Pharmacotherapy|November 25, 2024
Improving pharmacokinetic/pharmacodynamic outcomes of antimicrobial therapy for pneumonia in the ICUMichael Thy, Sophie Magréault, Jean-Ralph Zahar, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 31, 2025
Heteroresistance in Pseudomonas aeruginosa ventilator-associated pneumonia: a neglected hypothesis for a clinical impasseKhalil Chaïbi, Sophie Nagle, Typhaine Billard-Pomares, et al.
American Journal of Infection Control|July 21, 2015
Medical students' knowledge of infection control and prevention: Factors associated with better results and room for improvementClément Legeay, Valérie Thépot-Seegers, Matthieu Groh, et al.
Nature Communications|January 12, 2022
Rapid antigen testing as a reactive response to surges in nosocomial SARS-CoV-2 outbreak riskDavid R M Smith, Audrey Duval, Jean Ralph Zahar, et al.
Antibiotics (Basel, Switzerland)|March 25, 2022
Empiric Treatment in HAP/VAP: "Don't You Want to Take a Leap of Faith?"Khalil Chaïbi, Gauthier Péan de Ponfilly, Laurent Dortet, et al.
Microorganisms|April 3, 2021
Nosocomial Pneumonia in the Era of Multidrug-Resistance: Updates in Diagnosis and ManagementElena Xu, David Pérez-Torres, Paraskevi C Fragkou, et al.
Pageof 19

Showing results (31-40 of 190) with videos related to

Sort By:
Pageof 19
BMC Infectious Diseases|April 27, 2013
Limits of patient isolation measures to control extended-spectrum beta-lactamase-producing Enterobacteriaceae: model-based analysis of clinical data in a pediatric wardMatthieu Domenech de Cellès, Jean-Ralph Zahar, Véronique Abadie, et al.
Critical Care (London, England)|June 29, 2017
Treatment of severe hospital-acquired and ventilator-associated pneumonia: a systematic review of inclusion and judgment criteria used in randomized controlled trialsEmmanuel Weiss, Wafa Essaied, Christophe Adrie, et al.
Diagnostic Microbiology and Infectious Disease|December 23, 2019
Impact of freeze/thaw cycles and single freezing at -80 °C on the viability of aerobic bacteria from rectal swabs performed with the ESwab<sup>TM</sup> systemRindala Saliba, Jean Ralph Zahar, Fatma El Allaoui, et al.
Annals of Intensive Care|November 12, 2017
Piperacillin-tazobactam as alternative to carbapenems for ICU patientsBenoit Pilmis, Vincent Jullien, Alexis Tabah, et al.
Expert Opinion on Pharmacotherapy|November 25, 2024
Improving pharmacokinetic/pharmacodynamic outcomes of antimicrobial therapy for pneumonia in the ICUMichael Thy, Sophie Magréault, Jean-Ralph Zahar, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 31, 2025
Heteroresistance in Pseudomonas aeruginosa ventilator-associated pneumonia: a neglected hypothesis for a clinical impasseKhalil Chaïbi, Sophie Nagle, Typhaine Billard-Pomares, et al.
American Journal of Infection Control|July 21, 2015
Medical students' knowledge of infection control and prevention: Factors associated with better results and room for improvementClément Legeay, Valérie Thépot-Seegers, Matthieu Groh, et al.
Nature Communications|January 12, 2022
Rapid antigen testing as a reactive response to surges in nosocomial SARS-CoV-2 outbreak riskDavid R M Smith, Audrey Duval, Jean Ralph Zahar, et al.
Antibiotics (Basel, Switzerland)|March 25, 2022
Empiric Treatment in HAP/VAP: "Don't You Want to Take a Leap of Faith?"Khalil Chaïbi, Gauthier Péan de Ponfilly, Laurent Dortet, et al.
Microorganisms|April 3, 2021
Nosocomial Pneumonia in the Era of Multidrug-Resistance: Updates in Diagnosis and ManagementElena Xu, David Pérez-Torres, Paraskevi C Fragkou, et al.
Pageof 19